Tag: Renal disease

As a potent, active form of vitamin D, calcitriol's most significant and common adverse effect is an increase in blood calcium levels, a condition known as hypercalcemia. This medication, frequently prescribed for patients with kidney disease or hypoparathyroidism, necessitates consistent monitoring to mitigate this and other potential adverse effects.

Calciphylaxis is a rare but devastating condition with a mortality rate that can exceed 50% within a year. While often associated with end-stage renal disease, its development is frequently linked to medication use, leading many to ask: **Which drug causes calciphylaxis** and what are the specific pharmacological risks?

Over 78% of people taking alpha-glucosidase inhibitors may experience gastrointestinal side effects, highlighting the importance of proper patient selection. Before initiating treatment, healthcare providers and patients must understand **what are the contraindications to therapy with alpha-glucosidase inhibitors** to avoid serious complications and ensure treatment efficacy.

Farxiga, a medication used for type 2 diabetes, heart failure, and kidney disease, can increase the risk of dehydration, a condition that can be worsened by diarrhea. While clinical studies do not list diarrhea as a primary, common side effect of Farxiga alone, it can occur, particularly when combined with other drugs like metformin. Managing any fluid loss, including from diarrhea, is critical for patients taking Farxiga to prevent serious complications.

Cinacalcet (brand name Sensipar) is a calcimimetic agent that works by increasing the sensitivity of the calcium-sensing receptors on the parathyroid glands to extracellular calcium. It is an important medication for controlling high parathyroid hormone (PTH) levels, and the generic version offers a potentially more affordable option for many patients.

While modern antiretroviral therapy (ART) has significantly extended the lifespan of people living with HIV, studies show that older medications like tenofovir disoproxil fumarate (TDF) can contribute to kidney damage. This guide will explore the question of whether antiretroviral drugs cause kidney failure, outlining the specific risks associated with certain medications and advancements that have made treatment safer.

Hyperkalemia, a dangerous condition caused by abnormally high potassium levels in the blood, can lead to life-threatening heart rhythm problems. The medication sodium polystyrene sulfonate, often known by the brand name Kayexalate, is a potassium-removing agent used to treat this condition. It works in the intestines by exchanging sodium for excess potassium, which is then eliminated from the body.

As an angiotensin II receptor blocker (ARB), olmesartan's primary purpose is to treat high blood pressure by relaxing blood vessels and making it easier for the heart to pump blood. This action helps prevent serious cardiovascular issues like heart attacks and strokes.

Over one-third of adult patients undergoing dialysis for chronic kidney disease (CKD) suffer from hyperphosphatemia, a dangerous condition caused by an excess of phosphate in the blood. It is in these critical cases that **sevelamer carbonate is used for** to help control and lower dangerously high phosphate levels.

Over-the-counter medications for urinary pain relief, such as Azo, are a popular temporary solution for UTI symptoms, but they are not safe for everyone. It is critical to understand the specific health conditions and circumstances where using Azo can be dangerous.